Drug search by name

Omacetaxine Mepesuccinate and Myelosuppression

Result of checking the interaction of drug Omacetaxine Mepesuccinate and disease Myelosuppression for safety when used together.

Check result:

Omacetaxine Mepesuccinate <> Myelosuppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of omacetaxine might cause hematological toxicities. Patients with neutropenia are at increased risk for infections, and should be monitored frequently and advised to contact a physician if they have symptoms of infection or fever. It is recommended to monitor complete blood counts (CBCs) weekly during induction and initial maintenance cycles and every two weeks during later maintenance cycles, as clinically indicated. After initial maintenance cycles, monitor CBCs every two weeks or as clinically indicated. Care should be exercised when using omacetaxine in patients with hematological disorders.

Omacetaxine Mepesuccinate

Generic Name: omacetaxine

Brand Name: Synribo

Synonyms: Omacetaxine

What is Omacetaxine Mepesuccinate?